247patrick |
Cohen’s Point72 Boosts Stake in Praxis Precision Medicines Ahead of Phase 3 Trials
Point72 Asset Management has tripled its position in Praxis Precision Medicines, a clinical-stage biopharmaceutical company specializing in central nervous system disorders.